EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro

Longhua Liang, Xiaohui Huang, Guoxi Qin, Xiaoyu Ma, Rijing He, Hongpeng Dai, Zhen Zhang, Xiaogan Yang, Xingwei Liang

Frontiers in Microbiology · 02.07.2025 · 16

DOI: 10.3389/fmicb.2025.1611600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 02.07.2025. Verfasst von Longhua Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Guangxi University, Nanning, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine reproductive and respiratory syndrome virus (PRRSV) infection has inflicted devastating impacts on the global swine industry, while current vaccines provide limited protection against this disease. Mogroside V (MV), a triterpenoid compound derived from Siraitia grosvenorii, exhibits diverse biological activities including antioxidant, anti-inflammatory, and anti-cancer properties, with the capacity to scavenge free radicals and mitigate oxidative stress. In this study, MV was administered to PRRSV-infected cells via three distinct treatment modalities. Our findings demonstrate that MV effectively blocks or suppresses infections caused by diverse PRRSV subtypes in porcine alveolar macrophages (PAMs) and Marc-145 cells. MV exhibited significant dose-dependent antiviral efficacy, with viral titers and mRNA expression inhibited by over 90% at a concentration of 400 μM. Comparative analysis further revealed substantial variations in antiviral efficacy among the different treatment protocols. Notably, PRRSV employs immune evasion mechanisms to suppress host innate immunity. MV not only directly inhibited PRRSV replication but also significantly upregulated the gene expression of immunomodulatory cytokines (IL-1, IL-2, IL-8, IL-18; P < 0.05), suggesting a dual mechanism of antiviral action. These findings underscore the antiviral bioactivity of MV and highlight its potential as a novel therapeutic candidate for PRRSV intervention.

Schlagwörter

Stichwörter der Autor:innen

PRRSVantioxidantantiviral actioncytokinesmogroside V

Autor:innen und Institutionen

  • College of Animal Science and Technology, Guangxi University, Nanning, China.
  • Guangxi Key Laboratory of Animal Breeding & Disease Control and Prevention, Guangxi University, Nanning, China.
  • Guangxi Agricultural Reclamation Yongxin Livestock Group Jinguang Livestock Co., Ltd, Nanning, China.

Förderung

  • Guangxi Key Research and Development Program

Zitieren

APA

Liang, L., Huang, X., Qin, G., Ma, X., He, R., Dai, H., Zhang, Z., Yang, X., & Liang, X. (2025). Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1611600

Vancouver

Liang L, Huang X, Qin G, Ma X, He R, Dai H, et al. Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1611600

BibTeX
@article{Liang2025,
  author = {Liang, Longhua and Huang, Xiaohui and Qin, Guoxi and Ma, Xiaoyu and He, Rijing and Dai, Hongpeng and Zhang, Zhen and Yang, Xiaogan and Liang, Xingwei},
  title = {Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1611600}
}
Kostenlos starten →